Get Integrated Data for Your Specialty and Interest Aresa
Category Select :
Items 21 ~ 40 of 25713, Page 2 of 1287
21. Survivor Faces Endometrial Cancer Diagnosis With Strength and Hope - 12/24/2018
 American Cancer Society
  When she learned she had endometrial cancer, Tina Silas says she cried, but not for long. I had my 5 minutes of emotion, and then I moved forward, said Silas.
22. Year in Review: Cancer Research Insights from 2018 - 12/22/2018
 American Cancer Society
  Read highlights about American Cancer Society research from 2018.
23. 2018 in Review: CDC Looks Back at the Years Most Pressing Health Threats - 12/21/2018
 Centers for Disease Control and Prevention
  From the opioid overdose epidemic to foodborne disease outbreaks and antimicrobial resistance to the Ebola virus outbreak in the Democratic Republic of Congo (DRC), CDC worked around the clock ? and around the globe ? to protect Americans from health threats in 2018.
24. FDA permits marketing of a diagnostic test to aid in measuring nutrients in breast milk - 12/21/2018
  Miris Human Milk Analyzer, a new diagnostic test to aid healthcare professionals in measuring nutrients in breast milk, including the concentration of fat, carbohydrate, protein, total solids and energy
25. New Data Show Growing Complexity of Drug Overdose Deaths in America - 12/21/2018
 Centers for Disease Control and Prevention
  In-depth analysis confirms sharp increases, geographic spread of synthetic opioid-related deaths
26. FDA approves first treatment for rare blood disease - 12/21/2018
  Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients, two years of age and older
27. FDA approves new treatment for adult patients with rare, life-threatening blood disease - 12/21/2018
  Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disease
28. FDA sends warning to company for marketing dangerous unapproved stem cell products that put patients at risk and puts other stem cell firms, providers on notice - 12/20/2018
  Genetech, Inc. warned about umbilical cord blood-derived cellular products distributed by Liveyon, LLC. FDA is also sending letters to other firms and providers offering stem cell treatments notifying them of agencys regenerative medicine policy framework.
29. Deadly Marburg Virus Found in Sierra Leone Bats - 12/20/2018
 Centers for Disease Control and Prevention
  First time this Ebola-like virus identified in West Africa
30. FDA warns about safety risks of teething necklaces, bracelets to relieve teething pain or to provide sensory stimulation - 12/20/2018
31. Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen the long-term safety oversight of the Essure device following discontinuation of its U.S. sales - 12/20/2018
  FDA continues to evaluate the products long-term safety profile past its scheduled discontinuation from the U.S. market following a series of earlier regulatory actions that we took apply significant new requirements on its use. This includes the agencys decision to take the step of making Essure a restricted device
32. LYNPARZA (olaparib) Meets Primary Endpoint in Phase 3 SOLO-3 Trial for the Treatment of Relapsed BRCA-Mutated Advanced Ovarian Cancer - 12/20/2018
  AstraZeneca and Mercks LYNPARZA Significantly Improved Objective Response Rate Compared to Chemotherapy in Platinum-Sensitive Relapsed Patients Who Had Two or More Prior Lines of Chemotherapy
33. Statement from FDA Commissioner Scott Gottlieb, M.D., on signing of the Agriculture Improvement Act and the agencys regulation of products containing cannabis and cannabis-derived compounds - 12/20/2018
34. Merck Provides Update on KEYTRUDA (pembrolizumab) Supplemental Biologics License Application (sBLA) for KEYNOTE-042 Trial - 12/20/2018
  Mercks anti-PD-1 therapy, as monotherapy for the first-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in patients whose tumors express PD-L1 (tumor proportion score [TPS] 1%) without EGFR or ALK genomic tumor aberrations
35. New Study Finds Higher than Expected Number of Suicide Deaths among U.S. Veterinarians - 12/20/2018
 Centers for Disease Control and Prevention
  Female veterinarians at particularly high suicide risk
36. LYNPARZA (olaparib) Approved by FDA for First-Line Maintenance Therapy in BRCA-Mutated Advanced Ovarian Cancer - 12/19/2018
  AstraZeneca and Mercks LYNPARZA Reduced the Risk of Disease Progression or Death by 70 Percent Compared to Placebo Following Response to Platinum-Based Chemotherapy / First PARP Inhibitor Approved in First-Line Maintenance for BRCAm Advanced Ovarian Cancer
37. Almost 4% of Cancers Worldwide Due to Excess Body Weight - 12/19/2018
 American Cancer Society
  Excess body weight is responsible for an estimated 544,300 cancers, which is about 3.9% of all cancers in the world, according to research by the American Cancer Society, Imperial College London, and the Harvard T.H. Chan School of Public Health.
38. Medtronic Completes Acquisition of Mazor Robotics - 12/19/2018
  Company Integrates Robotics and Aims to Make Spine Surgery More Predictable and Transform Outcomes for Hospitals, Surgeons, and Patients
39. FDA Approves Mercks KEYTRUDA (pembrolizumab) for the Treatment of Adult and Pediatric Patients with Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma, a Rare Form of Skin Cancer - 12/19/2018
  Accelerated Approval Based on Results of CITN-09/KEYNOTE-017, Where KEYTRUDA Monotherapy Demonstrated an Objective Response Rate of 56 percent
40. Get Bubbly this New Year with Abbott''s New Pedialyte Sparkling Rush Powder Packs - 12/19/2018
  Pedialyte Sparkling Rush is advanced rehydration with a fizz, with an optimal balance of electrolytes and carbohydrate to prevent mild to moderate dehydration
<<  <  [1]  [2[3]  [4]  [5]  [6]  [7]  [8]  [9]  [10]  >  >>

Copyright ~2018 by Medisurf. All Rights Reserved Terms of Service Privacy Email :